24 May 2013
Keywords: cytheris, starts, phase, trial, hiv, drug, paris
Article | 18 July 2005
Paris, France-based biopharmaceutical group Cytheris, which focuses on immunomodulation, has initiated two new Phase I clinical studies with
its lead ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 July 2005
25 July 2005
23 May 2013
© 2013 thepharmaletter.com